- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Senate Agreement on COVID-19 Legislative and Funding Package
AMGA appreciates Congress’ efforts during this critical situation and will continue to work with key House and Senate leaders to ensure the federal response to COVID-19 is informed by the experience and recommendations of our members, who are responsible for the care of one in three Americans.
March 25, 2020 — Alexandria, VA – Today, the Senate reached agreement on a legislative package that includes critical funding to address the shortage of personal protective equipment (PPE) that AMGA members need to care for patients during this public health emergency. AMGA members are on the frontlines of combatting the novel coronavirus (COVID-19) and any shortage of crucial supplies, such as N95 masks, will compromise their ability to treat patients and prevent further spread of the virus. AMGA’s membership is ready to work with federal, state, and local officials to obtain these needed supplies as soon as possible.
The Senate package also includes $100 billion for healthcare providers to respond to COVID-19. H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) and an accompanying emergency appropriations package provides funding to cover lost revenues that result from this pandemic. AMGA members are working diligently to treat their patients while keeping their providers and community as safe as possible.
As part of their COVID-19 response, AMGA members have cancelled their elective surgeries and procedures and are encouraging their patients to stay home. The CARES Act recognizes the significant financial challenges this creates for group practices and integrated health systems.
Read the full press release here.
Inside the Center's MDD Value Model and Its Use of Dynamic Pricing
May 13th 2025Larragem Raines, MS, of the Center for Innovation & Value Research, discusses the organization's major depressive disorder (MDD) open-source value model, dynamic pricing, and the future role of artificial intelligence in care.
Listen
Community Oncology Reacts to Trump's Drug Pricing Executive Order
May 2nd 2025An executive order signed on Tuesday, March 15, necessitated a change in plans for this panel discussion from the 2025 Community Oncology Conference, with the assembled experts, moderated by Ted Okon, MBA, executive director of the Community Oncology Alliance, speaking to how the order would reverberate across the community oncology space.
Read More
Advancing the Art of Medicine Through Partnership
April 29th 2025Oncology leaders from Alliance Cancer Specialists, American Oncology Network, CHI St. Vincent, Memorial Sloan Kettering Cancer Center, and New York Cancer & Blood Specialists discussed the power of collaboration in cancer care, highlighting partnerships that enhance patient outcomes and resource sharing in community practices.
Read More
